Leadership Page

Our bench strength.

From leading research minds to extensive market knowledge, our leadership team brings together the expertise and experienced oversight to advance our goal of leveraging cancer breakthroughs to build viable commercial opportunities.

Management

Management

David O’Neill, PhD

President

David O’Neill brings extensive experience in Pharma, Biotech and seed stage investing to his role as President of FACIT.  Dr. O’Neill has a wealth of networks and transaction experience through various business development roles at... 

David-Oneill-img

Nicole Baryla, PhD

Director, Alliance and Project Management

Dr. Nicole Baryla joined the FACIT team with 12 years combined experience in not-for-profit organizations, biotech start-up companies, the pharmaceutical industry, and academic research settings...

Nicole-Baryla-img

Connie Chen, PhD

Director, Business Intelligence and Strategy

Dr. Connie Chen joined FACIT in 2013 with over 12 years of experience in the life sciences, biotechnology and capital markets sectors. Several leadership roles in both the corporate world as well as in the capital markets...

Connie-Chen-img

David Koehler, PhD, CLP

Director, Fund Operations

Dr. David Koehler joined OICR’s Commercialization group in 2007.  His responsibilities include managing the Intellectual Property Development and Commercialization (IPDC) Fund...

David-Koehler-img

Lisa Milestone, PhD, P.Eng.

Senior Project Manager

Dr. Lisa Milestone joined the FACIT team with 10 years combined experience in academic research settings and technical consulting...

Lisa-Milestone-img

Brent Zanke, MD, FRCPC, PhD

Executive-in-Residence

Dr. Brent Zanke consults widely on matters of biomarkers, laboratory molecular pathology, innovation policy and health care delivery systems...

Brent-Zanke-img

Frank Gleeson, BBA, MBA

Executive-in-Residence

Mr. Frank Gleeson has more than 20 years of leadership and business building experience as an operating executive and venture capitalist. During his career, he has completed more than $300 million...

Frank-Gleeson-img

Robert M. Sutherland, BSc, PhD

Senior Investment Advisor

Dr. Robert Sutherland facilitates and advises FACIT in the identification of projects for early stage development and the engagement of market receptors and investor groups...

Bob-Sutherland-img

Board of Trustees

Board of Trustees

John Morrison, BSc

Mr. John Morrison is a retired chief executive and has been an active corporate director of leading companies and voluntary organizations. He has been responsible for operations in Canada, the U.S., Europe and Asia...

Ken Lawless, MSc

Mr. Ken Lawless has been very active in promoting investment in, and commercialization of, life sciences companies and technologies in Canada...

Har Grover, MBA, ICD.D

Mr. Har Grover is an entrepreneur, investor, senior executive and strategist with over 30 years of experience in healthcare....

Kevin Empey, CPA, ICD.D

Mr. Kevin Empey is currently the Supervisor of Brockville General Hospital.  Prior to this role, he was President and Chief Executive Officer of Lakeridge Health for 8 years.... 

Shana Kelley, PhD

Dr. Shana Kelley is a Distinguished Professor of Biochemistry, Pharmaceutical Sciences, Chemistry, and Biomedical Engineering at the University of Toronto. Dr. Kelley received....